Genetic Engineering & Biotechnology News: Bacterial Platforms Can Rival Mammalian Platforms | Absci Genetic Engineering & Biotechnology News: Bacterial Platforms Can Rival Mammalian Platforms - Absci

06.05.2021

Genetic Engineering & Biotechnology News: Bacterial Platforms Can Rival Mammalian Platforms

Absci CEO and Founder Sean McClain spoke with GEN about how its Escherichia coli platforms are engineered to defy known cell line limitations and enable high-titer scale-up of challenging biologics. Read more.